A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

Stopped Study was terminated due to COVID-19 pandemic and recruitment challenges in the parent study (GWND18064 - NCT03848832).

Conditions

• Rett Syndrome
• RTT

Interventions

• DRUG: GWP42003-P

Sponsor

Jazz Pharmaceuticals

Collaborators

• [object Object]